scispace - formally typeset
E

Eugenia Panaitescu

Researcher at Carol Davila University of Medicine and Pharmacy

Publications -  42
Citations -  615

Eugenia Panaitescu is an academic researcher from Carol Davila University of Medicine and Pharmacy. The author has contributed to research in topics: Melanoma inhibitory activity & Weibull distribution. The author has an hindex of 10, co-authored 42 publications receiving 488 citations.

Papers
More filters
Journal Article

Survival rates of patients with metastatic malignant melanoma.

Angela Sandru, +3 more
- 01 Oct 2014 - 
TL;DR: The influence of metastases distribution on the overall survival was examined and it was noticed that there were statistically significant differences between the risks of death of various groups of patients, depending on metastasis topography.
Journal ArticleDOI

Value of acoustic radiation force impulse imaging elastography for non-invasive evaluation of patients with nonalcoholic fatty liver disease.

Carmen Fierbinteanu Braticevici, +3 more
- 01 Nov 2013 - 
TL;DR: ARFI elastography is a promising method for differentiating patients with non-alcoholic steatohepatitis from patients with simple steatosis and can also predict significant fibrosis in these patients.
Journal Article

Prognostic significance of KRAS gene mutations in colorectal cancer--preliminary study.

D Dinu, +9 more
- 01 Oct 2014 - 
TL;DR: It was not found that KRAS gene status had any prognostic significance, but for stage I and II patients, the mutation found on codon 13 determined a statistic significant shorter survival rate than for those with wild type.
Journal Article

Bayes estimators of Modified-Weibull distribution parameters using Lindley's approximation

Vasile Preda, +2 more
- 01 Jul 2010 - 
TL;DR: In this paper, the Bayes Estimators of scale and shape parameters using Lindley's approximation (L-approximation) under various loss functions are compared with the corresponding MLE for their risks based on corresponding simulated samples.
Journal Article

KRAS gene mutations - prognostic factor in colorectal cancer?

Maria Dobre, +9 more
- 01 Jan 2015 - 
TL;DR: A retrospective study on 74 patients treated by radical surgery found that for the patients in stage IV pTNM, the evolution was slightly better in association with a KRAS mutation than in wild type cases, and tried to appreciate the prognostic value of these mutations.